Form D — DiaMedica Therapeutics Inc.
0001437749-25-023439 · filed 2025-07-25
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $30,100,000
- Total sold
- $30,100,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- DiaMedica Therapeutics Inc.
- CIK
- 1401040
- Entity
- Corporation
- Jurisdiction
- CANADA (FEDERAL LEVEL)
- Year incorporated
- —
- Address
- 301 CARLSON PARKWAY
MINNEAPOLIS, MN 55305 - Phone
- (763) 496-5454
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Rick Pauls · Executive OfficerMinneapolis, MN Find on LinkedIn ↗
-
Scott Kellen · Executive OfficerMinneapolis, MN Find on LinkedIn ↗
-
Lorianne Masuoka · Executive OfficerMinneapolis, MN Find on LinkedIn ↗
-
David J. Wambeke · Executive OfficerMinneapolis, MN Find on LinkedIn ↗
-
Michael R. Giuffre · DirectorMinneapolis, MN Find on LinkedIn ↗
-
Richard Kuntz · DirectorMinneapolis, MN Find on LinkedIn ↗
-
Tanya N. Lewis · DirectorMinneapolis, MN Find on LinkedIn ↗
-
James T. Parsons · DirectorMinneapolis, MN Find on LinkedIn ↗
-
Daniel O'Connor · DirectorMinneapolis, MN Find on LinkedIn ↗
-
Charles P. Semba · DirectorMinneapolis, MN Find on LinkedIn ↗
View original on SEC EDGAR.